TNF and skin reaction: TNF-alpha inhibitors, such as adalimumab, etanercept, infliximab, certolizumab pegol, and golimumab, are widely used to manage inflammatory diseases, yet they have been associated with unexpected skin reactions, including the emergence of new lesions or changes in pre-existing conditions [29].